We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.75%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$104B
AUM Growth
+$8.72B
(+9.1%)
Cap. Flow
-$256M
Cap. Flow
% of AUM
-0.25%
Top 10 Holdings %
Top 10 Hldgs %
26.49%
Holding
4,372
New
62
Increased
2,195
Reduced
1,544
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$35.4M |
| 2 |
P
Everpure Inc
P
|
+$21M |
| 3 |
NVIDIA
NVDA
|
+$20.7M |
| 4 |
American Homes 4 Rent
AMH
|
+$19.3M |
| 5 |
DAY
Dayforce
DAY
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$46.7M |
| 2 |
Apple
AAPL
|
+$41.8M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$32.3M |
| 4 |
Gilead Sciences
GILD
|
+$27.8M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$25.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.42% |
| 2 | Financials | 13.09% |
| 3 | Healthcare | 11.94% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPRX
1426
DELISTED
Catalyst Pharmaceutical
CPRX
| $4.99M | ﹤0.01% |
312,964
+24,043
| +8% | +$362K |
|
1427
Hilltop Holdings
HTH
$2.24B
| $4.95M | ﹤0.01% |
158,122
-1,049
| -0.7% | -$33.3K |
|
1428
iShares MSCI ACWI ex US ETF
ACWX
$11.9B
| $4.95M | ﹤0.01% |
92,653
-1,994
| -2% | -$102K |
|
|
ARI
1429
Apollo Commercial Real Estate
ARI
$880M
| $4.92M | ﹤0.01% |
441,987
+3,420
| +0.8% | +$38.3K |
|
1430
John Wiley & Sons Class A
WLY
$2.63B
| $4.92M | ﹤0.01% |
128,903
-5,364
| -4% | -$184K |
|
|
SWTX
1431
DELISTED
SpringWorks Therapeutics
SWTX
| $4.9M | ﹤0.01% |
99,575
+4,511
| +5% | +$209K |
|
|
FOLD
1432
DELISTED
Amicus Therapeutics
FOLD
| $4.89M | ﹤0.01% |
415,121
+12,481
| +3% | +$160K |
|
1433
Green Brick Partners
GRBK
$3.06B
| $4.89M | ﹤0.01% |
81,178
-1,438
| -2% | -$77.1K |
|
1434
Hayward Holdings
HAYW
$3.32B
| $4.89M | ﹤0.01% |
319,258
-20,965
| -6% | -$280K |
|
1435
Northwest Bancshares
NWBI
$2.29B
| $4.87M | ﹤0.01% |
417,787
+1,830
| +0.4% | +$21.7K |
|
|
PRMW
1436
DELISTED
Primo Water Corporation
PRMW
| $4.82M | ﹤0.01% |
264,927
-660
| -0.2% | -$10.4K |
|
1437
PROG Holdings
PRG
$1.69B
| $4.81M | ﹤0.01% |
139,739
-1,490
| -1% | -$46.9K |
|
1438
Teva Pharmaceuticals
TEVA
$41B
| $4.81M | ﹤0.01% |
341,051
+8,259
| +2% | +$104K |
|
1439
Helix Energy Solutions
HLX
$1.44B
| $4.79M | ﹤0.01% |
442,264
+1,239
| +0.3% | +$12.1K |
|
1440
Brown-Forman Class A
BF.A
$13.1B
| $4.79M | ﹤0.01% |
90,439
-4,598
| -5% | -$263K |
|
1441
NCR Voyix
VYX
$1.13B
| $4.77M | ﹤0.01% |
377,378
-27,574
| -7% | -$397K |
|
1442
National Healthcare
NHC
$3.41B
| $4.76M | ﹤0.01% |
50,371
-9,559
| -16% | -$905K |
|
|
AXNX
1443
DELISTED
Axonics, Inc. Common Stock
AXNX
| $4.76M | ﹤0.01% |
68,955
-582
| -0.8% | -$39.3K |
|
1444
First Commonwealth Financial
FCF
$2.19B
| $4.75M | ﹤0.01% |
341,448
-3,658
| -1% | -$50.5K |
|
|
UNIT
1445
Uniti Group
UNIT
$2.28B
| $4.72M | ﹤0.01% |
799,804
+4,017
| +0.5% | +$23K |
|
1446
Northwest Natural Holdings
NWN
$2.09B
| $4.71M | ﹤0.01% |
126,575
+3,739
| +3% | +$140K |
|
1447
Phinia Inc
PHIN
$2.72B
| $4.71M | ﹤0.01% |
122,497
-7,588
| -6% | -$247K |
|
1448
Hecla Mining
HL
$11.3B
| $4.69M | ﹤0.01% |
974,493
+21,651
| +2% | +$86.4K |
|
1449
SiTime
SITM
$21.4B
| $4.69M | ﹤0.01% |
50,274
+682
| +1% | +$71.7K |
|
1450
PagSeguro Digital
PAGS
$2.55B
| $4.67M | ﹤0.01% |
326,954
+9,878
| +3% | +$131K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2024 Portfolio in Review
As of Q1 2024, RhumbLine Advisers held 4,372 positions worth $104B, up 9.1% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3%. RhumbLine Advisers opened 62 new positions and exited 71, leaving the 4,372-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2024 buy was Dayforce: 278,394 shares worth $18.4M.
- RhumbLine Advisers added most to Amazon in Q1 2024, an estimated $35.4M increase.
- RhumbLine Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $46.7M.
- RhumbLine Advisers fully exited Splunk Inc in Q1 2024, selling an estimated $32.3M.
- RhumbLine Advisers's ten largest holdings make up 26% of its $104B portfolio in Q1 2024.
- RhumbLine Advisers opened 62 new positions and closed 71 in Q1 2024.
- RhumbLine Advisers's portfolio value rose 9.1% quarter-over-quarter to $104B.
Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.